This trial is suspended!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non-small Cell Lung Cancer Metastatic
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

An open-label, prospective, single-arm, multi-center phase IV clinical trial of TarcevaTM as single agent

Provided treatments

  • Drug: Erlotinib

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320501. The sponsor of the trial is National Guard Health Affairs and it is looking for 100 volunteers for the current phase.
Official trial title:
Real Life Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer in the Middle Eastern Countries (REALME)